MediTek now has its portfolio of products designed, engineered and developed in collaboration with the clinical and patient/carer-centered focus groups. The products are classed as FDA Class 1 Device* (classed as protective binder for patients) complying with relevant risk and regulatory standards. The vests were developed with input from oncology and renal specialists but are suitable for many other line recipients, such as:

​

• Bone Marrow Transplants

• Cardiac

• Patients with Haematology, Immunology, Metabolic conditions

• Pulmonary Hypertension

• Cystic Fibrosis 

 

Additional products launching in Q4 2023 include Connected HeroVest;

 

• Patient's vital signs

• SpO2 levels (For early Covid-19 detection)

• Body temperature

• Respiration rate

• Heart beat monitor

• Wearable devices

 
All with remote monitoring and location based information (GPS) via app or online dashboard. This will save time and cost for Doctor visits for both Patients and Medical professionals.

​

​

​

* FDA Section 880.5160 Therapeutic medical binder classification.